Yoji Inoue
Hiroshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoji Inoue.
International Journal of Urology | 2011
Yoji Inoue; Keisuke Goto; Tetsutaro Hayashi; Mutsuo Hayashi
Objectives: To assess the long‐term outcomes of transrectal high‐intensity focused ultrasound (HIFU) for patients with localized prostate cancer.
International Journal of Urology | 2007
Takahisa Nakamoto; Yoji Inoue; Tetsuhiro Ueki; Naomasa Niimi; Yasumasa Iwasaki
Abstract: The case is reported of amelanotic malignant melanoma of the female urethra mimicking urethral caruncle. A 75‐year‐old woman complained of a mass of the external meatus. Urethral carunclectomy was performed, but histological diagnosis was amelanotic malignant melanoma. Finally, she underwent en block resection of urethra including bladder neck, uterus, adnexa, vagina, and vulva. As urinary diversion, she underwent a continent cathererizable stoma with an appendicovesicostomy, according to the method described by Mitrofanoff, and Y‐V graft for reconstruction of the vulva.
Neurourology and Urodynamics | 2009
Yoji Inoue; Koji Mita; Masayuki Kakehashi; Masao Kato; Tsuguru Usui
The aim of this study was to clarify the prevalence of painful bladder syndrome (PBS) symptoms in adult women in the general population in Japan.
BJUI | 2016
Jun Teishima; Kohei Kobatake; Hiroyuki Kitano; Hirotaka Nagamatsu; Kousuke Sadahide; Keisuke Hieda; Shunsuke Shinmei; Koichi Shoji; Shogo Inoue; Tetsutaro Hayashi; Yoji Inoue; Shinya Ohara; Koji Mita; Akio Matsubara
To investigate the impact of pretreatment serum C‐reactive protein (CRP) level and its change after targeted therapy on the anti‐tumour effect of targeted agents in patients with metastatic renal cell carcinoma (mRCC).
The Journal of Sexual Medicine | 2008
Koji Mita; Masayuki Kakehashi; Yasuhisa Hasegawa; Yoji Inoue; Masanobu Shigeta; Akio Matsubara; Tsuguru Usui
INTRODUCTION Some Japanese women are known to have negative attitudes toward erectile dysfunction (ED) drugs, but the environment underlying these perceptions is unclear. AIM To reveal the underlying environment that shapes womens perceptions of ED drugs in Japan. METHODS A web-based questionnaire was conducted through an Internet-based market research company. A total of 2,593 women in five age groups (20s, 30s, 40s, 50s, and 60s or older) were randomly invited to participate in this study, with an almost equal number in each age group. The questionnaire contained 30 items related to individual background and sexual information, concerns about the image of ED drugs, ED drug-related perceptions, and attitude toward sexual information media. MAIN OUTCOME MEASURES The womens attitude and the independent predictors that affect their partners use of ED drugs were clarified. RESULTS Answers were obtained from 1,077 women, of whom 35.4% (n=381) had a negative image of ED drugs. Although 69.5% (n=749) agreed that a sexual relationship with a male partner was important, only 26.7% (n=288) agreed that this remained important if ED drugs were used. However, 56.7% (n=611) and 57.7% (n=621) of respondents, respectively, answered that they would allow their partners use of ED drugs if they imagined that they understood the safety and effectiveness of ED drugs and that their quality of life was improved by their partners use of the drugs. Lack of information about ED drugs was a significant predictor for acceptance of a partners use of ED drugs among women with a negative image of ED drugs, since they were more likely to accept the use of these drugs if they were convinced about their safety and effectiveness or positive effect on quality of life. CONCLUSION Lack of information about ED drugs may influence the perception of women in Japan regarding these drugs.
Molecular and Clinical Oncology | 2017
Keisuke Goto; Hirotaka Nagamatsu; Jun Teishima; Yuki Kohada; Shinsuke Fujii; Yoshimasa Kurimura; Koji Mita; Masanobu Shigeta; Satoshi Maruyama; Yoji Inoue; Mitsuru Nakahara; Akio Matsubara
Prostate cancer, one of the most common malignant tumors among men, is closely associated with obesity and, thus far, several studies have suggested the association between obesity and aggressive pathological characteristics in the United States. However, the effect of obesity on prostate cancer mortality is controversial, and it remains unclear whether obesity contributes to the aggressiveness of prostate cancer in Asian patients. The aim of the present study was to investigate the association between body mass index (BMI) and the clinicopathological characteristics of prostate cancer in 2,003 Japanese patients who underwent radical prostatectomy. There was a significant association between higher BMI and higher Gleason score (GS). The multivariate analysis also revealed that BMI was an independent indicator for GS ≥8 at surgery. Moreover, among patients with lower prostate-specific antigen levels, biochemical recurrence-free survival was significantly worse in those with higher BMI. These results suggest that BMI may be a classifier for predicting adverse pathological findings and biochemical recurrence after radical prostatectomy in Japanese patients.
Maturitas | 2007
Koji Mita; Masanobu Shigeta; Masayuki Kakehashi; Akio Matsubara; Jun Teishima; Masao Kato; Mitsuhiro Seki; Yasuhisa Hasegawa; Yoji Inoue; Tsuguru Usui
Nishinihon Journal of Urology | 2001
K. Kobayashi; Masanobu Shigeta; Yoji Inoue; Takahisa Nakamoto; Tsuguru Usui; Fumio Shimamoto; Y. Murakami
Open Journal of Urology | 2017
Mutsuo Hayashi; Tetsutaro Hayashi; Kiyotaka Oka; Keisuke Goto; Shunsuke Shinmei; Yoji Inoue; Katsumi Inoue
The Journal of Urology | 2011
Tetsutaro Hayashi; Keisuke Goto; Kiyotaka Oka; Yoji Inoue; Mutsuo Hayashi